Singclean Medical will make a strong appearance at IMCAS World Congress 2026, taking place in Paris, France from January 29 to 30, 2026, further reinforcing its commitment to innovation and academic development in the aesthetic medical field.

Singclean Booth:H122

At IMCAS 2026, Singclean Medical will highlight its flagship product Singderm, a Mono-pharse sodium hyaluronate gel for injection designed for external contour shaping and filling. Developed to meet the growing demand for refined facial contouring, Singfiller reflects Singclean Medical’s continued focus on product performance, safety, and clinical precision.

In addition to Singfiller, the company will also showcase its advanced aesthetic portfolio, including PDRN and PLLA, two product categories that continue to gain global attention for their regenerative and collagen-stimulating properties. Together, these offerings demonstrate Singclean Medical’s comprehensive capabilities in aesthetic medicine.

As an active contributor to the global aesthetic medical industry, Singclean Medical plays a multifaceted role. Through continuous investment in research and development, the company drives product innovation. By delivering high-quality and reliable solutions, it supports clinicians in achieving optimized treatment outcomes. Moreover, through participation in leading international congresses such as IMCAS, Singclean Medical strengthens academic exchange and global industry collaboration.

Academic development remains a core strategic focus for Singclean Medical. By engaging in academic dialogue, professional education, and international exchange, the company continues to enhance its academic credibility while reinforcing confidence in the safety and efficacy of its products.

Looking ahead, Singclean Medical will further expand its global presence by deepening international partnerships, increasing academic investment, and advancing innovation in aesthetic medicine. Through ongoing participation in global congresses and academic initiatives, the company remains committed to shaping the future of the aesthetic medical industry.